Risk of perforation after colonoseopy and sigmoidoscopy: A population-based study

被引:358
作者
Gatto, NM
Frucht, H
Sundararajan, V
Jacobson, JS
Grann, VR
Neugut, AI
机构
[1] Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
[2] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA
[3] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY USA
[4] Monash Univ Sch Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
关键词
D O I
10.1093/jnci/95.3.230
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although the risk of bowel perforation is often cited as a major factor in the choice between colonoscopy and sigmoidoscopy for colorectal screening, good estimates of the absolute and relative risks of perforation are lacking. Methods: We used a large population-based cohort that consisted of a random sample of 5% of Medicare beneficiaries living in regions of the United States covered by the Surveillance, Epidemiology, and End Results (SEER) Program registries to determine rates of perforation in people aged 65 years and older. We identified individuals who were cancer-free and had undergone colonoscopy or sigmoidoscopy between 1991 and 1998, calculated both the incidence and risk of perforation within 7 days of the procedure, and explored the impact on incidence and risk of perforation of age, race/ethnicity, sex, comorbidities, and indication for the procedure. We also estimated the risk of death after perforation. Risks were calculated with odds ratios (ORs) and 95% confidence intervals (Cls). All statistical tests were two-sided. Results: There were 77 perforations after 39286 colonoscopies (incidence = 1.96/1000 procedures) and 31 perforations after 35 298 sigmoidoscopies (incidence = 0.88/1000 procedures). After adjustment, the OR for perforation from colonoscopy relative to perforation from sigmoidoscopy was 1.8 (95% CI = 1.2 to 2.8). Risk of perforation from either procedure increased in association with increasing age (P-trend<.001 for both procedures) and the presence of two or more comorbidities (P-trend<.001 for colonoscopy and P-trend = .03 for sigmoidoscopy). Compared with those who were endoscopied and did not have a perforation, the risk of death was statistically significantly increased for those who had a perforation after either colonoscopy (OR = 9.0, 95% CI = 3.0 to 27.3) or sigmoidoscopy (OR = 8.8, 95% CI = 1.6 to 48.5). The risk of perforation after colonoscopy, especially for screening procedures, declined during the 8-year study, period. Conclusions: The risk of perforation after colonoscopy is approximately double that after sigmoidoscopy, but this difference appears to be decreasing. These observations should be useful to clinicians making screening and diagnostic decisions for individual patients and to policy officials setting guidelines for colorectal cancer screening programs.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 39 条
[1]   Endoscopic perforation of the colon: Lessons from a 10-year study [J].
Anderson, ML ;
Pasha, TM ;
Leighton, JA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (12) :3418-3422
[2]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[3]   Screening for colon cancer - Can we afford colonoscopy? [J].
Detsky, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (08) :607-608
[4]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[5]   Complications and adverse effects of colonoscopy with selective sedation [J].
Eckardt, VF ;
Kanzler, G ;
Schmitt, T ;
Eckardt, AJ ;
Bernhard, G .
GASTROINTESTINAL ENDOSCOPY, 1999, 49 (05) :560-565
[6]   THE ACCURACY OF MEDICARES HOSPITAL CLAIMS DATA - PROGRESS HAS BEEN MADE, BUT PROBLEMS REMAIN [J].
FISHER, ES ;
WHALEY, FS ;
KRUSHAT, WM ;
MALENKA, DJ ;
FLEMING, C ;
BARON, JA ;
HSIA, DC .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (02) :243-248
[7]  
FRUHMORGEN P, 1979, ENDOSCOPY, V11, P146
[8]   The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status [J].
Gohagan, JK ;
Prorok, PC ;
Hayes, RB ;
Kramer, BS .
CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :251S-272S
[9]  
HARDCASTLE JD, 1986, CANCER-AM CANCER SOC, V58, P397, DOI 10.1002/1097-0142(19860715)58:2<397::AID-CNCR2820580235>3.0.CO
[10]  
2-X